Senkyunolide H protects against MPP+-induced apoptosis via the ROS-mediated mitogen-activated protein kinase pathway in PC12 cells
Autor: | Xueqin Li, Weicheng Hu, Aftab Yaseen, Yufeng Cao, Wancai Zheng, Jianmei Zhang, Chuanling Si, Tingwu Liu, Fengting Sun, Yunyao Jiang, Yanyan Luo |
---|---|
Rok vydání: | 2019 |
Předmět: |
Pharmacology
MAPK/ERK pathway chemistry.chemical_classification 0303 health sciences biology Chemistry Health Toxicology and Mutagenesis Cytochrome c p38 mitogen-activated protein kinases Glutathione peroxidase General Medicine 010501 environmental sciences Toxicology medicine.disease_cause 01 natural sciences Neuroprotection Superoxide dismutase 03 medical and health sciences Mitogen-activated protein kinase biology.protein medicine Oxidative stress 030304 developmental biology 0105 earth and related environmental sciences |
Zdroj: | Environmental Toxicology and Pharmacology. 65:73-81 |
ISSN: | 1382-6689 |
DOI: | 10.1016/j.etap.2018.12.007 |
Popis: | Senkyunolide H (SNH) is a phthalide isolated from the rhizome of Ligusticum chuanxiong Hort. that has been reported to have several pharmacological activities, including anti-atherosclerotic, antiproliferative, and cytoprotective effects. In this study, we investigated the neuroprotective effects and potential mechanisms of SNH against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress. We demonstrated that SNH pretreatment significantly attenuated MPP+-induced neurotoxicity and apoptosis in PC12 cells. In addition, SNH attenuated the effect of MPP+ on the expression of the pro-apoptotic factors Bax and caspase-3. Meanwhile, SNH prevented oxidative stress by reducing reactive oxygen species generation, mitochondrial membrane potential loss, cytochrome C release, and malondialdehyde levels while increasing antioxidant enzyme activity (e.g., superoxide dismutase, catalase, and glutathione peroxidase). In addition, SNH inhibited nuclear accumulation of nuclear factor-κB and c-Jun N-terminal kinase and phosphorylation p38 mitogen-activated protein kinases (MAPKs). Overall, this investigation provides novel evidence that SNH exerts neuroprotective effects via the ROS-mediated MAPK pathway and represents a potential preventive or therapeutic agent for neuronal disorders. |
Databáze: | OpenAIRE |
Externí odkaz: |